OTCMKTS:EDTXF Spectral Diagnostics (EDTXF) Stock Price, News & Analysis $1.03 +0.01 (+0.78%) As of 05/8/2026 03:22 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Spectral Diagnostics Stock (OTCMKTS:EDTXF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Spectral Diagnostics alerts:Sign Up Key Stats Today's Range$1.00▼$1.0350-Day Range$0.92▼$1.0852-Week Range$0.58▼$1.31Volume13,337 shsAverage Volume7,337 shsMarket Capitalization$301.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. Read More Receive EDTXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spectral Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EDTXF Stock News HeadlinesSpectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate UpdateMay 8 at 7:30 AM | globenewswire.comSpectral Diagnostics (EDTXF) Expected to Announce Earnings on FridayMay 1, 2026 | americanbankingnews.comThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.May 10 at 1:00 AM | Porter & Company (Ad)Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate UpdateMarch 26, 2026 | globenewswire.comSpectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory MedicineMarch 24, 2026 | globenewswire.comSpectral Medical Provides Update on PMA Submission Timing for PMX-20RFebruary 26, 2026 | globenewswire.comSpectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate UpdateNovember 13, 2025 | theglobeandmail.comSpectral Medical Inc. Files Base Shelf Prospectus and Revised AIFSeptember 29, 2025 | globenewswire.comSee More Headlines EDTXF Stock Analysis - Frequently Asked Questions How have EDTXF shares performed this year? Spectral Diagnostics' stock was trading at $1.02 at the start of the year. Since then, EDTXF stock has increased by 0.8% and is now trading at $1.0280. How were Spectral Diagnostics' earnings last quarter? Spectral Diagnostics Inc. (OTCMKTS:EDTXF) announced its quarterly earnings results on Friday, May, 8th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.00. The company had revenue of $0.64 million for the quarter, compared to the consensus estimate of $0.54 million. How do I buy shares of Spectral Diagnostics? Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/08/2026Today5/10/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:EDTXF Previous SymbolOTCMKTS:DIAGF CIKN/A Webwww.spectraldx.com Phone(416) 626-3233Fax416-626-7383Employees29Year Founded1991Profitability EPS (Trailing Twelve Months)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$34.13 million Net Margins-1,955.89% Pretax Margin-1,952.57% Return on EquityN/A Return on Assets-802.16% Debt Debt-to-Equity RatioN/A Current Ratio0.08 Quick Ratio0.07 Sales & Book Value Annual Sales$1.75 million Price / Sales172.36 Cash FlowN/A Price / Cash FlowN/A Book Value($0.17) per share Price / Book-6.05Miscellaneous Outstanding Shares293,420,000Free Float289,018,000Market Cap$301.64 million OptionableNot Optionable Beta0.09 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (OTCMKTS:EDTXF) was last updated on 5/10/2026 by MarketBeat.com Staff. From Our PartnersThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredWhy U.S. Bank CEOs Are Panicking Right NowWhy U.S. Bank CEOs Are Panicking Right Now Treasury Secretary Bessent and Fed Chair Powell recently summone...Chaikin Analytics | SponsoredElon’s Biggest Launch Ever: 15x Bigger Than SpaceXThe Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...InvestorPlace | SponsoredCollect $1,170 a month from silverI've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...Investors Alley | SponsoredThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...Behind the Markets | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
